Medical Writing. A few dates ago, Biosim, the employer of the biosimilar medicine, celebrated one year of existence. In the interview with Redacción Médica, Regina Múzquiz, its general director, explains the strategy planned by the association to facilitate the introduction of biosimilars in the SNS, a process in which she hopes that the 'battle' that took place will not be repeated when the generic drug landed in Spain, with resistance that "in some cases were not very legitimate."